SCHEMBL6604986

SCHEMBL6604986

COCCNC(=O)COc1ccc2c(c1)C(N(CCOC)S(C)(=O)=O)CC(C)(C)O2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.45
ALDH1A1 P00352 6/20 0.42
KDM4E B2RXH2 5/20 0.42
GAA P10253 5/20 0.42
GLA P06280 2/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MAPT P10636 2/20 0.41
HTT P42858 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
NPC1 O15118 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
LMNA P02545 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KCNE1 P15382 2/20 0.38
KCNQ1 P51787 2/20 0.38
CASP1 P29466 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6603004 0.93 HPGD (0.45) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6607000 0.89 ALDH1A1 (0.45) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6601635 0.87 KCNE1 (0.40) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6601925 0.85 KCNE1 (0.44) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6601917 0.84 ALDH1A1 (0.45) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6601715 0.84 KCNE1 (0.42) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6604472 0.83 KCNE1 (0.45) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6601750 0.81 KCNE1 (0.43) HPGDALDH1A1KDM4EGAAGLA
SCHEMBL6606045 0.81 KCNE1 (0.53) ALDH1A1MEN1KMT2AMAPTHTT
SCHEMBL6603289 0.81 KCNE1 (0.44) ALDH1A1KDM4EGAAGLAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906911-B1 Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them AVENTIS PHARMA GMBH (DE) 2004-04-28 EP disclosed
US-6177449-B1 CARDIOVASCULAR DISORDERS; ANTIULCER AGENTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-01-23 US disclosed
EP-0906911-A1 Sulfonamid-substituted chromane derivatives (K+channel-blocker), process for their preparation, their use as drugsand pharmaceutical compositions containing them Hoechst Marion Roussel Deutschland GmbH (DE) 1999-04-07 EP disclosed